Exemption of SLNB After Neoadjuvant Therapy for Triple-negative and Her2-positive Breast Cancer

NCT07498400 · clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
216
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Xijing Hospital